The L’Oreal SA (LRLCY) Given Average Rating of “Hold” by Analysts

The L’Oreal SA (LRLCY) Given Average Rating of “Hold” by Analysts

L’Oreal SA (OTCMKTS:LRLCY) has received an average recommendation of “Hold” from the twelve ratings firms that are currently covering the company. Two analysts have rated the stock with a sell recommendation, six have assigned a hold recommendation and four have given a buy recommendation to the company. Several research firms recently weighed in on LRLCY. Zacks Investment Research cut L’Oreal SA from a “hold” rating to a “sell” rating in a research note on Tuesday, July 26th. Berenberg Bank assumed coverage on L’Oreal SA in a research note on Friday,…

The KeyCorp (KEY) Upgrade to Buy by The Zacks Investment Research

The KeyCorp (KEY) Upgrade to Buy by The Zacks Investment Research

KeyCorp (NYSE:KEY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The brokerage currently has a $19.00 price objective on the financial services provider’s stock. Zacks Investment Research’s price objective indicates a potential upside of 13.57% from the stock’s current price. According to Zacks, “KeyCorp’s third quarter 2016 adjusted earnings surpassed the Zacks Consensus Estimate as synergies from the First Niagara deal were impressive. Higher revenues were partially offset by a rise in expenses and provision for credit losses….

The Hancock Holding Co. (HBHC) Decreased to “Hold” at The Zacks Investment Research

The Hancock Holding Co. (HBHC) Decreased to “Hold” at The Zacks Investment Research

Hancock Holding Co. (NASDAQ:HBHC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Thursday. According to Zacks, “Hancock’s third-quarter 2016 earnings surpassed the Zacks Consensus Estimate on higher revenues and a decline in expenses. However, an energy-led rise in provisions remained the undermining factor. The company's efforts to streamline its business are expected to reduce costs and improve efficiency. Further, the company's efforts to upgrade online banking facility is expected to lower expenses in the quarters ahead and its strategic…

The Radian Group Inc. (RDN) Lowered by The Zacks Investment Research

The Radian Group Inc. (RDN) Lowered by The Zacks Investment Research

Radian Group Inc. (NYSE:RDN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Thursday. According to Zacks, “Radian Group’s third-quarter 2016 earnings outperformed the Zacks Consensus Estimate and also improved year over year. Notably, the company witnessed the highest volume of new flow mortgage insurance business written in the third quarter of 2016. Radian Group is poised for long-term growth on expansive mortgage and real estate service offerings, declining delinquency, lower levels of paid claims and improving risk-based capital…

The Prothena Corp. (PRTA) Upgrade to Buy at The Zacks Investment Research

The Prothena Corp. (PRTA) Upgrade to Buy at The Zacks Investment Research

Prothena Corp. (NASDAQ:PRTA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday. The brokerage presently has a $72.00 price target on the stock. Zacks Investment Research’s price objective indicates a potential upside of 11.87% from the stock’s previous close. According to Zacks, “Prothena’s third-quarter results were disappointing with the company posting a wider-than-expected loss. Nevertheless, its license agreement with Roche for the development and commercialization of selected antibodies targeting alpha-synuclein is a big positive. The collaboration…

The Zacks Investment Research lowers the Stock rating of Northern Trust Corp. (NTRS)

The Zacks Investment Research lowers the Stock rating of Northern Trust Corp. (NTRS)

Northern Trust Corp. (NASDAQ:NTRS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday. According to Zacks, “Northern Trust’s third-quarter 2016 earnings were in line with the Zacks Consensus Estimate and improved from the year-ago quarter. Results reflected rise in revenue driven by higher net interest income as well as non-interest income. Also, continued growth in assets under custody as well as assets under management acted as tailwind. However, higher operating expenses were the downside. The company continues…

The Lincoln National Corp. (LNC) Lowered by The Zacks Investment Research

The Lincoln National Corp. (LNC) Lowered by The Zacks Investment Research

Lincoln National Corp. (NYSE:LNC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday. According to Zacks, “Lincoln National is well positioned for long-term growth, given its focus on reducing exposure to business with long-term guarantee. The company also remains immune to the  rule proposed by the DOL. Its strong capital position is another positive. Moreover, the company has a solid balance sheet owing to prudent capital deployment and improvement in book value. However, the company’s growth has been restricted…

The KeyCorp (KEY) Stock Rating Upgrade by The Zacks Investment Research

The KeyCorp (KEY) Stock Rating Upgrade by The Zacks Investment Research

KeyCorp (NYSE:KEY) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday. The brokerage presently has a $19.00 price objective on the financial services provider’s stock. Zacks Investment Research’s target price would indicate a potential upside of 13.57% from the company’s previous close. According to Zacks, “KeyCorp’s third quarter 2016 adjusted earnings surpassed the Zacks Consensus Estimate as synergies from the First Niagara deal were impressive. Higher revenues were partially offset by a rise in expenses and provision for…

The Zacks Investment Research Downgraded Hancock Holding Co. (HBHC) to Hold

The Zacks Investment Research Downgraded Hancock Holding Co. (HBHC) to Hold

Hancock Holding Co. (NASDAQ:HBHC) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday. According to Zacks, “Hancock’s third-quarter 2016 earnings surpassed the Zacks Consensus Estimate on higher revenues and a decline in expenses. However, an energy-led rise in provisions remained the undermining factor. The company's efforts to streamline its business are expected to reduce costs and improve efficiency. Further, the company's efforts to upgrade online banking facility is expected to lower expenses in the quarters ahead and its strategic…

The CA, Inc. (CA) Upgrade at The Zacks Investment Research

The CA, Inc. (CA) Upgrade at The Zacks Investment Research

CA, Inc. (NYSE:CA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday. The firm currently has a $35.00 price target on the stock. Zacks Investment Research’s price target indicates a potential upside of 11.18% from the stock’s previous close. According to Zacks, “CA is a leading information technology (IT) management software company founded in 1974 and headquartered in Islandia, NY. CA’s strategy of expanding the cloud business through acquisitions is impressive. The wide range of products should attract customers…

The Celldex Therapeutics Inc. (CLDX) Upgrade by The Zacks Investment Research to Buy

The Celldex Therapeutics Inc. (CLDX) Upgrade by The Zacks Investment Research to Buy

Celldex Therapeutics Inc. (NASDAQ:CLDX) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Thursday. The firm currently has a $5.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research’s price objective indicates a potential upside of 14.16% from the stock’s current price. According to Zacks, “Celldex’s third-quarter results were encouraging with the company reporting narrower-than-expected loss and revenues surpassing expectations. The company’s efforts to build its immuno-oncology pipeline are also impressive.  The upcoming Kolltan acquisition bodes well for the…

The Chemed Corp. (CHE) Upgrade to Hold at The Zacks Investment Research

The Chemed Corp. (CHE) Upgrade to Hold at The Zacks Investment Research

Chemed Corp. (NYSE:CHE) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Thursday. According to Zacks, “Chemed’s third-quarter 2016 results were a mixed bag, with its bottom line lagging the Zacks Consensus Estimate while revenues exceeded the same. Issues related to declining units for admission remain a headwind. VITAS demonstrated a sluggish show, but we are optimistic about the strong segmental performances at the company. Furthermore, the raised outlook for both the Roto-Rooter segment and bottom-line results is indicative…

The Research Analysts’ Recent Ratings Updates for Qualys (QLYS)

The Research Analysts’ Recent Ratings Updates for Qualys (QLYS)

Qualys (NASDAQ: QLYS) has recently received a number of price target changes and ratings updates: Shares of Qualys Inc. (NASDAQ:QLYS) traded up 0.55% during midday trading on Thursday, hitting $36.30. 126,003 shares of the stock traded hands. The stock has a market capitalization of $1295.62 billion, a P/E ratio of 46.54 and a beta of 1.09. The firm has a 50-day moving average price of $37.15 and a 200-day moving average price of $33.12. Qualys Inc. has a 52 week low of $16.96 and a 52 week high of $39.74….

The Constellation Brands Inc. (STZ) Raised to Buy at The Zacks Investment Research

The Constellation Brands Inc. (STZ) Raised to Buy at The Zacks Investment Research

Constellation Brands Inc. (NYSE:STZ) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday. The firm currently has a $172.00 price target on the stock. Zacks Investment Research’s price target indicates a potential upside of 12.17% from the company’s previous close. According to Zacks, “Constellation Brands boasts a portfolio of well-known brands and is the largest wine company in the world, which gives it a competitive edge and bolsters its solid market position. The company’s focus on…

The S&P Global Inc. (SPGI) Upgrade at The Zacks Investment Research

The S&P Global Inc. (SPGI) Upgrade at The Zacks Investment Research

S&P Global Inc. (NYSE:SPGI) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. The brokerage presently has a $137.00 price target on the stock. Zacks Investment Research’s target price would indicate a potential upside of 11.96% from the stock’s previous close. According to Zacks, “S&P Global continues to impress investors with better-than-expected earnings for the 15th consecutive quarter. Further, the company surpassed the revenues estimate for the second straight quarter. Top-line growth was mainly supported by strong…

The Companhia de Saneamento Basico do Estado de Sao Paulo (SBS) Decreased to Hold at The Zacks Investment Research

The Companhia de Saneamento Basico do Estado de Sao Paulo (SBS) Decreased to Hold at The Zacks Investment Research

Companhia de Saneamento Basico do Estado de Sao Paulo (NYSE:SBS) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Thursday. According to Zacks, “SABESP's long-term prospects remain bright, as growth in the Brazilian population is leading to higher demand for water and sewage services. The company aims to achieve 95% sewage coverage ratio and add 1.4 million new sewage connections by 2020 and nearly 1 million water connections by 2021. Also, it has planned investments worth R$12.5…

The Zacks Investment Research Upgraded PVH Corp. (PVH) to Buy

The Zacks Investment Research Upgraded PVH Corp. (PVH) to Buy

PVH Corp. (NYSE:PVH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday. The brokerage currently has a $121.00 target price on the stock. Zacks Investment Research’s price target would indicate a potential upside of 11.93% from the stock’s previous close. According to Zacks, “Owner of premium Calvin Klein and Tommy Hilfiger brands – PVH’s diversified portfolio allows the company to stay ahead of its peers, to generate above-average industry growth and sustain its position in the current challenging…

The Prologis Inc. (PLD) Upgrade to “Buy” at The Zacks Investment Research

The Prologis Inc. (PLD) Upgrade to “Buy” at The Zacks Investment Research

Prologis Inc. (NYSE:PLD) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday. The brokerage presently has a $54.00 target price on the stock. Zacks Investment Research’s price target points to a potential upside of 12.17% from the stock’s previous close. According to Zacks, “Prologis came up with decent earnings results in the recent quarters, reporting funds from operations (FFO) per share surprise of 4.29% in the third quarter. Amid a consistent shift toward e-commerce and supply…

The MasterCard Inc. (MA) Cut to “Hold” at The Zacks Investment Research

The MasterCard Inc. (MA) Cut to “Hold” at The Zacks Investment Research

MasterCard Inc. (NYSE:MA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday. According to Zacks, “MasterCard’s earnings per share beat the Zacks Consensus Estimate and were up year over year on a rise in the number of processed transactions and an increase in cross-border volumes, partly offset by higher rebates and incentives. MasterCard’s product-diversification and geographic-expansion initiatives augur well for the long term. Its multiple acquisitions over the past couple of years are also boosting inorganic growth. The recently…

The Associated Banc-Corp (ASB) Decreased to Hold at The Zacks Investment Research

The Associated Banc-Corp (ASB) Decreased to Hold at The Zacks Investment Research

Associated Banc-Corp (NYSE:ASB) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. According to Zacks, “Associated Banc-Corp’s third-quarter 2016 earnings surpassed the Zacks Consensus Estimate. Continued top-line growth was partly offset by higher operating expenses and a drastic rise in credit costs. The company is expected to continue witnessing organic growth, driven by improving loan and deposit balances. In addition, the company’s branch consolidation efforts and inorganic growth strategy will likely enhance profitability going forward. However,…